Literature DB >> 23401634

Personalizing healthcare: from genetics through payment to improving care?

A E Finlayson1, B Godman, K Paterson, E Aston, A Haycox, L L Gustafsson, R Ali.   

Abstract

Mesh：

Year:  2013        PMID： 23401634      PMCID： PMC3569018          DOI： 10.1258/jrsm.2012.120193

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  14 in total

1.  Personalized medicine. New cystic fibrosis drug offers hope, at a price.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2012-02-10       Impact factor: 47.728

Review 2.  Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.

Authors:  Brian Godman; Björn Wettermark; Mikael Hoffmann; Karolina Andersson; Alan Haycox; Lars L Gustafsson
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2009-02       Impact factor: 2.217

Review 3.  CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis.

Authors:  Michael V Holmes; Pablo Perel; Tina Shah; Aroon D Hingorani; Juan P Casas
Journal:  JAMA       Date:  2011-12-28       Impact factor: 56.272

4.  Polygenes, risk prediction, and targeted prevention of breast cancer.

Authors:  Paul D P Pharoah; Antonis C Antoniou; Douglas F Easton; Bruce A J Ponder
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

Review 5.  Pharmacogenetics in drug discovery and development: a translational perspective.

Authors:  Allen D Roses
Journal:  Nat Rev Drug Discov       Date:  2008-09-19       Impact factor: 84.694

6.  Effect of direct-to-consumer genomewide profiling to assess disease risk.

Authors:  Cinnamon S Bloss; Nicholas J Schork; Eric J Topol
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

Review 7.  Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.

Authors:  Hans-Georg Eichler; Eric Abadie; Alasdair Breckenridge; Bruno Flamion; Lars L Gustafsson; Hubert Leufkens; Malcolm Rowland; Christian K Schneider; Brigitte Bloechl-Daum
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

Review 8.  Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.

Authors:  J A Johnson; L Gong; M Whirl-Carrillo; B F Gage; S A Scott; C M Stein; J L Anderson; S E Kimmel; M T M Lee; M Pirmohamed; M Wadelius; T E Klein; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2011-09-07       Impact factor: 6.875

Review 9.  The clinical utility of precision medicine: properly assessing the value of emerging diagnostic tests.

Authors:  B Shen; J Hwang
Journal:  Clin Pharmacol Ther       Date:  2010-12       Impact factor: 6.875

10.  Estimation of the warfarin dose with clinical and pharmacogenetic data.

Authors:  T E Klein; R B Altman; N Eriksson; B F Gage; S E Kimmel; M-T M Lee; N A Limdi; D Page; D M Roden; M J Wagner; M D Caldwell; J A Johnson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 91.245
View more
  3 in total

1.  Personalised medicine and National Health Service culture.

Authors:  Edward H Reynolds
Journal:  J R Soc Med       Date:  2013-05       Impact factor: 5.344

Review 2.  An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.

Authors:  Antony Martin; Jennifer Downing; Michelle Maden; Nigel Fleeman; Ana Alfirevic; Alan Haycox; Munir Pirmohamed
Journal:  Pharmacogenomics       Date:  2017-11-02       Impact factor: 2.533

Review 3.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.